Chemoinformaics analysis of Methyl pentyl tetrasulfide
| Molecular Weight | 214.446 | nRot | 7 |
| Heavy Atom Molecular Weight | 200.334 | nRig | 0 |
| Exact Molecular Weight | 213.998 | nRing | 0 |
| Solubility: LogS | -5.529 | nHRing | 0 |
| Solubility: LogP | 3.165 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 30.9551 |
| nHD | 0 | BPOL | 16.5049 |
| QED | 0.452 |
| Synth | 3.349 |
| Natural Product Likeliness | 1.354 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.005 |
| HIA | 0.005 |
| CACO-2 | -4.686 |
| MDCK | 0.0000276 |
| BBB | 0.837 |
| PPB | 0.621695 |
| VDSS | 1.143 |
| FU | 0.188322 |
| CYP1A2-inh | 0.952 |
| CYP1A2-sub | 0.912 |
| CYP2c19-inh | 0.987 |
| CYP2c19-sub | 0.866 |
| CYP2c9-inh | 0.887 |
| CYP2c9-sub | 0.827 |
| CYP2d6-inh | 0.08 |
| CYP2d6-sub | 0.474 |
| CYP3a4-inh | 0.035 |
| CYP3a4-sub | 0.227 |
| CL | 10.233 |
| T12 | 0.072 |
| hERG | 0.339 |
| Ames | 0.6 |
| ROA | 0.805 |
| SkinSen | 0.963 |
| Carcinogencity | 0.234 |
| EI | 0.994 |
| Respiratory | 0.986 |
| NR-Aromatase | 0.217 |
| Antiviral | No |
| Prediction | 0.964027 |